Medical centers
Gastrointestinal Manifestations in Juvenile-Onset Systemic Sclerosis Characterized Using UCLA Scleroderma Clinical Trial Consortium Instrument
Researchers at the University of Pittsburgh Medical Center have conducted a study to characterize gastrointestinal manifestations in juvenile-onset systemic sclerosis (jSSc) using the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract 2.0 (UCLA GIT 2.0) patient-reported outcome (PRO) instrument. The study found that distension/bloating and reflux were the